Results 81 to 90 of about 676,789 (144)

Impact of Sequential Ramucirumab Plus Docetaxel After PD-1 Inhibitors on Anti-PD-1 Antibody-Bound T-Cell Dynamics and Clinical Outcomes. [PDF]

Cancer Sci
Matsumoto K, Naito Y, Shiroyama T, Tamiya M, Nishino K, Tamiya A, Okishio K, Kinehara Y, Kuge T, Mori M, Satoh S, Suzuki H, Tetsumoto S, Niki T, Suga Y, Osa A, Minami T, Koyama S, Takeda Y, Takakura N, Kumanogoh A.   +20 more
europepmc   +1 more source

Immune checkpoint blockade targets macrophage PD-1 to exacerbate metabolic dysfunction. [PDF]

Immunometabolism (Cobham)
Song Z, Frezza C.
europepmc   +1 more source

Strategies to target PD-1/PD-L1 in the tumor microenvironment. [PDF]

Cell Oncol (Dordr)
Kui Y, Tong F, Zhang R, Dong X, Wang J.
europepmc   +1 more source

Peripheral Blood Biomarkers Predict Outcomes in Advanced Cancers Treated With Anti-PD-1 Therapy. [PDF]

Immun Inflamm Dis
Feng C, Li P, Gu Q, Chen M, Gu J.
europepmc   +1 more source

CCR5+ CD8+ T Cells Are Associated with Poor Response to PD-1 Blockade Therapy. [PDF]

Int J Mol Sci
Zhao Z, Liu Y, Wu Z, Qi C, Ning Y, Lin Y, Pang X, Qiang G, Wang W.   +8 more
europepmc   +1 more source

Engineering strategies and binding mechanisms of therapeutic anti-PD-1 antibodies approved by regulatory agencies globally. [PDF]

Front Immunol
Almagro JC, Gómez-Castellano K, Licona-Limón I, Carballo Uicab GJ, Ramírez-Villedas FD, Montes-Luna A, González-González E, Godínez-Palma S, Barrera Saldaña HA, Pérez-Tapia SM.   +9 more
europepmc   +1 more source

The Prognostic Value of the CD8⁺PD-1⁺/CD4⁺PD-1⁺ (PERLS) Ratio for Leukemic Transformation in MDS. [PDF]

Hematol Rep
Panagiotidis P, Karavanis E, Neanidis K, Panteris E, Moysidou M.   +4 more
europepmc   +1 more source

Nanomaterial-based strategies overcome PD-1 related intrinsic immune resistance. [PDF]

Cancer Drug Resist
Lin Y, Shen J.
europepmc   +1 more source

The role of PD‑1/PD‑L1 axis in liver diseases. [PDF]

Clin Exp Med
Zeng Z, Chen S, Niu Q, Dong H, Yao Y, Wang K, Gong X, Li H.   +7 more
europepmc   +1 more source

Regulation of antiviral immunity by PD-1 during respiratory syncitial virus infection and upon vaccination. [PDF]

iScience
Rodríguez-Guilarte L, Méndez C, Rojas MF, Pereira-Sánchez P, Ríos M, Muñoz JT, Farías MA, Bueno SM, Kalergis AM.   +8 more
europepmc   +1 more source